Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Genetics in Medicine
  • View all journals
  • Search
  • Log in
  • Content Explore content
  • RSS feed
  1. nature
  2. genetics in medicine
  3. abstracts
  4. article
Optimal cancer risk assessment program professional roles; analysis of 30 American centers
Download PDF
Download PDF
  • Abstracts
  • Published: 01 January 2000

Abstract

Optimal cancer risk assessment program professional roles; analysis of 30 American centers

  • E R Knell1 &
  • C A Presant1 

Genetics in Medicine volume 2, page 68 (2000)Cite this article

  • 249 Accesses

  • Metrics details

Abstract

Genetic cancer risk assessment programs, until recently found only at major university and teaching hospitals, have moved into clinical use in community-based centers. While genetic counseling is recommended, little emphasis has been placed on what constitutes comprehensive risk assessment and counseling. As risk assessment has moved into community usage, little attention has been given to tbe types of professional or medical staff required for an effective, quality program. To better understand the scope and practices of existing programs, we surveyed members of the National Society of Genetic Counselor Cancer SIG. Here we report on some of our detailed findings from 30 programs who responded.

Most programs (23/30) relied on the genetic counselor as gatekeeper for entrance into the program, and an additional 4 had no restrictions. The majority of programs (21/30) did not involve a physician anytime during the first visit, yet most (23/30) presented risk figures at this time, thus relying on the expertise of the genetic counselor in education, as well as family history collection, evaluation and interpretation. The counselor spent a minimum of 5 hours per patient in pedigree analysis, counseling, informed consent and test interpretation. Many programs (11/30) relied on the counselor as the main or even sole contact, and often genetic testing decisions were at the discretion of the counselor. The more respected programs utilized the unique training and skills of the genetic counselor for risk assessment and counseling issues, as well as for communicating detailed knowledge of genetic risk and gene testing, while relying on the physician for expertise on medical management issues, tailored to the risk for the individual, considering their mutation status and the particular cancer syndrome.

We conclude, from this and additional data to be presented, that a balanced program requires the expertise and coordination both of a genetic counselor and an oncologist, as well as the availability of other professionals. The implementation of genetic testing without a genetic counselor poses risks for the patients: inadequate collection and genetic interpretation of the family history, only empiric risk analysis, as well as misunderstanding of genetic testing. Cancer risk programs are improved by physician consultation, particularly with description and consequences of possible interventions and promoting and monitoring compliance of individuals with recommendations.

Article PDF

Author information

Authors and Affiliations

  1. Los Angeles Oncologic Institute (LAOI) and California Cancer Medical Center, Los Angeles, CA

    E R Knell & C A Presant

Authors
  1. E R Knell
    View author publications

    Search author on:PubMed Google Scholar

  2. C A Presant
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Knell, E., Presant, C. Optimal cancer risk assessment program professional roles; analysis of 30 American centers. Genet Med 2, 68 (2000). https://doi.org/10.1097/00125817-200001000-00069

Download citation

  • Issue date: 01 January 2000

  • DOI: https://doi.org/10.1097/00125817-200001000-00069

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Download PDF

Advertisement

Explore content

  • Research articles
  • Reviews & Analysis
  • News & Comment
  • Current issue
  • Collections
  • Sign up for alerts
  • RSS feed

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Genetics in Medicine (Genet Med)

ISSN 1530-0366 (online)

ISSN 1098-3600 (print)

nature.com sitemap

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2025 Springer Nature Limited